Abliva

Abliva is committed to becoming a leading biopharmaceutical company in the field of mitochondrial medicine, developing therapies for primary mitochondrial diseases and orphan indications with highly unmet medical needs. The company will establish a fully integrated research, development, and commercial organization to develop innovative therapies and deliver them directly to patients.